EGFR was reported to be overexpressed in anaplastic thyroid carcinomas, follicular thyroid carcinomas and in primary medullary carcinomas, with no evidence of somatic EGFR mutations (31–34). The gene discussed is EGFR; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.